Adrián Noriega, M.D., Ph.D., is a physician-scientist specializing in Alzheimer’s disease and
neurovascular conditions, with a focus on clinical development and biomarker-driven trial
strategies. He serves as Senior Scientist in vascular and behavioral neurology at The Montreal
Neurological Institute-Hospital and the Department of Neurology and Neurosurgery at McGill
University, where he completed his clinical fellowship. Dr. Noriega is also the MIT-Novo
Nordisk AI Fellow at MIT and the Broad Institute, where he develops novel strategies for drug
development and delivery in neurodegenerative diseases.
In addition, Dr. Noriega is the Clinical Lead at Perceiv AI, a precision neurology company
focused on forecasting disease progression to optimize clinical trials. His work centers on
advancing biomarker science, precision trial design, and therapeutic development in Alzheimer’s
and related disorders. He has been recognized as an Emerging Leader by the World Heart
Federation, a Veterans Affairs-MIT Catalyst Fellow, and a member of the Forbes Technology
Council. His research has been supported by the Alzheimer’s Association, Brain Canada, and
CIHR, and he has been a leader in Alzheimer’s disease advocacy initiatives. Dr. Noriega also
serves on the Scientific Advisory Board of the Alzheimer Society of Montreal and has
contributed as an editorial board member for Stroke and the Canadian Journal of Cardiology.